financetom
Business
financetom
/
Business
/
Acadia Realty Trust Launches Offering of 4.5 Million Shares
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Acadia Realty Trust Launches Offering of 4.5 Million Shares
Oct 2, 2024 9:47 PM

04:41 PM EDT, 09/30/2024 (MT Newswires) -- Acadia Realty Trust ( AKR ) said Monday it's launching an underwritten public offering of 4.5 million shares in connection with forward sale agreements.

Wells Fargo Securities, Goldman Sachs and Jefferies are the joint book-running managers, the company said, adding underwriters will get a 30-day option to buy up to 675,000 additional shares. It expects to enter into forward sale agreements.

The shares may be offered by the underwriters from time to time to purchasers, the firm said.

The company said any proceeds upon future settlement of the forward sale agreements will be used for general corporate purposes.

Price: 23.19, Change: -0.29, Percent Change: -1.24

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Armada Hoffler Properties Prices $94.5 Million Stock Offering
Armada Hoffler Properties Prices $94.5 Million Stock Offering
Sep 26, 2024
03:22 AM EDT, 09/26/2024 (MT Newswires) -- Armada Hoffler Properties ( AHH ) said late Wednesday it has priced an underwritten public offering of 9 million common shares for about $94.5 million in gross proceeds. The underwriters have been granted a 30-day option to purchase up to 1.4 million additional shares. Net proceeds will be used for debt repayments, working...
Pharming Group Gets Marketing Approval in UK for Immunodeficiency Drug
Pharming Group Gets Marketing Approval in UK for Immunodeficiency Drug
Sep 26, 2024
03:17 AM EDT, 09/26/2024 (MT Newswires) -- Pharming Group ( PHAR ) said it has received marketing authorization in the UK for leniolisib for the treatment of activated phosphoinositide 3-kinase delta syndrome, a primary immunodeficiency. The drug is currently being evaluated for potential reimbursement within England's National Health Service, the company said. ...
BASF lowers 2025 dividend proposal to at least 2.25 eur per share
BASF lowers 2025 dividend proposal to at least 2.25 eur per share
Sep 26, 2024
(Reuters) - German chemicals giant BASF on Thursday lowered its dividend proposal for the 2024 business year to at least 2.25 euros ($2.51) per share as part of its new corporate strategy. The proposal compares to a 2024 annual dividend proposal of 3.40 euros per share reported in February, and a 2023 dividend the same amount. BASF said it will...
MDxHealth Prices $40 Million Stock Offering
MDxHealth Prices $40 Million Stock Offering
Sep 26, 2024
03:29 AM EDT, 09/26/2024 (MT Newswires) -- MDxHealth ( MDXH ) said late Wednesday it has priced a public offering of 20 million ordinary shares at $2 per share for gross proceeds of $40 million. The company said a strategic partner is buying 1.5 million shares directly from the company instead of through the underwriters. It also granted underwriters an...
Copyright 2023-2026 - www.financetom.com All Rights Reserved